NCT01086969 A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India Status COMPLETED Phase PHASE3
NCT01086254 SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01084252 Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT01082549 Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE3
NCT01082068 Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01081938 Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition Status TERMINATED Phase PHASE4
NCT01079364 Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting Status TERMINATED Phase PHASE4
NCT01076764 Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy Status COMPLETED Phase PHASE3
NCT01076751 Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients Status TERMINATED Phase N/A
NCT01074372 Ascending Dose Study of the Safety and Tolerability of REGN727 (SAR236553) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01064141 A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines Status COMPLETED Phase PHASE2
NCT01063946 A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid Tumor Status COMPLETED Phase PHASE1
NCT01062477 A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants Status COMPLETED Phase PHASE3
NCT01061736 Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients Status COMPLETED Phase PHASE2/PHASE3
NCT01061723 Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE2
NCT01055899 Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE1